Acurx Pharmaceuticals (ACXP) Cash from Financing Activities (2020 - 2026)
Acurx Pharmaceuticals (ACXP) recorded Cash from Financing Activities of $3.11 million in Q2 2026, up 0.7% from $3.09 million a year earlier and up 0.2% from the prior quarter.
Powered by 
Analysis
Acurx Pharmaceuticals (ACXP) Cash from Financing Activities (2020 - 2026) Analysis & Trends
On a TTM basis, Acurx Pharmaceuticals' Cash from Financing Activities came in at $10.78 million as of Jun 30, 2026, up 37.0% year-over-year; for FY2025, it was $10.64 million, up 60.8% from FY2024.
- Annual Cash from Financing Activities has a five-year compound annual growth rate of 21.3% (FY2020 to FY2025).
- Across earlier years, Cash from Financing Activities came in at $6.62 million in FY2024 (-19.0%), $8.16 million in FY2023 (+120.9%), $3.7 million in FY2022 (-75.0%) and $14.8 million in FY2021 (+265.9%).
- The Q2 2026 figure is the highest quarterly Cash from Financing Activities since Q1 2024.
- On a year-over-year basis, Cash from Financing Activities rose in four of the last six quarters, with growth averaging 124.8%.
- Per Business Quant, the preceding three quarters came in at $3.11 million (Q1 2026), $2.83 million (Q4 2025) and $1.72 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,148.13 Bn | 1,116.72 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 630.09 Bn | 548.62 Bn | 17.26 Bn | -8.78 Bn |
| 3 | AbbVie | 498.99 Bn | 472.10 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 374.92 Bn | 329.30 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 300.99 Bn | 264.98 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 264.63 Bn | 238.32 Bn | 12.86 Bn | -3.89 Bn |
| 7 | Amgen | 239.15 Bn | 194.55 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 192.23 Bn | 166.43 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | -3.66 Bn |
| 10 | Acurx Pharmaceuticals | 4.94 Mn | -28.52 Mn | - | 3.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.11 Mn |
| Mar 31, 2026 | 3.11 Mn |
| Dec 31, 2025 | 2.83 Mn |
| Sep 30, 2025 | 1.72 Mn |
| Jun 30, 2025 | 3.09 Mn |
| Mar 31, 2025 | 2.99 Mn |
| Dec 31, 2024 | 194,547.00 |
| Sep 30, 2024 | 1.59 Mn |
| Jun 30, 2024 | 320,211.00 |
| Mar 31, 2024 | 4.51 Mn |
| Dec 31, 2023 | 4.62 Mn |
| Dec 31, 2022 | -1.00 |
| Dec 31, 2020 | 728,537.00 |
| Sep 30, 2020 | 2.19 Mn |
API Access
Acurx Pharmaceuticals Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ACXP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "ACXP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ACXP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();